about
Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric DisordersParkinson's Disease: The Mitochondria-Iron LinkCardiotonic Steroids as Modulators of NeuroinflammationGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesNeuroinflammation in Parkinson's disease and its potential as therapeutic targetEndoplasmic Reticulum Stress Interacts With Inflammation in Human DiseasesNeuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugsMechanisms of granulin deficiency: lessons from cellular and animal modelsCellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's diseaseThe role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?M1 and M2 immune activation in Parkinson's Disease: Foe and ally?Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell deathOral microbiome link to neurodegeneration in glaucomaCB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease.Interferon Gamma: Influence on Neural Stem Cell Function in Neurodegenerative and Neuroinflammatory DiseaseEnvironmental Exposures and Parkinson's DiseaseSusceptibility to particle health effects, miRNA and exosomes: rationale and study protocol of the SPHERE studyInflamed In Vitro Retina: Cytotoxic Neuroinflammation and Galectin-3 ExpressionFurther structure-activity relationships study of substituted dithiolethiones as glutathione-inducing neuroprotective agentsModelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT scoreCerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease.Cerebral oedema is not responsible for motor or cognitive deficits in rats with hepatic encephalopathy.IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation.Lipocalin-2 Acts as a Neuroinflammatogen in Lipopolysaccharide-injected Mice.Developmental exposure to concentrated ambient ultrafine particulate matter air pollution in mice results in persistent and sex-dependent behavioral neurotoxicity and glial activation.Neuroprotective and Cognitive Enhancement Potentials of Angelica gigas Nakai Root: A Review.Sigma-1 receptor chaperones in neurodegenerative and psychiatric disordersHippocampal proliferation is increased in presymptomatic Parkinson's disease and due to microglia.Suppression of glia maturation factor expression prevents 1-methyl-4-phenylpyridinium (MPP⁺)-induced loss of mesencephalic dopaminergic neuronsA nicotinic receptor-mediated anti-inflammatory effect of the flavonoid rhamnetin in BV2 microglia.Inflammasomes in neuroinflammation and changes in brain function: a focused review.Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases.Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.Exploring Braak's Hypothesis of Parkinson's Disease.Mast cells and neuroinflammation.Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.Targeting GTPases in Parkinson's disease: comparison to the historic path of kinase drug discovery and perspectivesAbsence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonismDopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators.Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson's Disease.
P2860
Q26745690-277AAA70-B782-41AA-8D42-E9A68984A551Q26746899-3C60C43C-03D7-4CF0-BE50-EF390BCC7604Q26766722-BCFEE588-C305-43EB-82CD-514EB80A5561Q26767289-FFA98A4C-298D-4D78-B679-3A2D1C1E94B0Q26783305-D9A115A9-A5B6-4E90-A8C6-39ACBFE389C3Q26800781-3D08A77E-2977-4B0E-A0C1-FD3077696B6CQ26801035-92098CFF-497B-46EE-8DB5-5504172AADEFQ26824221-749C9E14-778B-40C0-AF11-FBD4A0688AFCQ26849232-58CA6CC2-452D-46CF-B751-09B7210C7289Q26861263-A46BC63A-335C-4DCE-90A7-F89D57AC50C6Q27024667-2B6BC2BC-1C76-46CC-A460-8A6D621F6A9AQ27300869-4477D07E-13CD-4E74-B379-1124528341B7Q27316016-EA78C128-8312-48F1-9F62-DB738A51763EQ27324500-5207632A-B564-4E45-976D-9568CCB96227Q27928023-0BEEDB3D-9C88-4691-BA9C-B4B350504982Q28074723-31C07D2B-D0F9-4E1E-8818-3BEAB4310D52Q28382944-F32CF8ED-5FAA-4214-886B-F273ECC56963Q28553963-0B627BFD-C058-47D8-98EB-C21D31C33C87Q28821625-FA2EC732-C13C-4551-87B6-65C31CD3E331Q29048624-CA050ABC-F381-4C1A-83C4-44FD6E763FB7Q30446890-028AC3D3-2394-4605-A06C-6338AFCC035EQ30656195-B9A35BE8-1330-4444-9948-198AD3310E74Q30664735-152235AC-EBB7-465E-B999-26A7D7B95C0AQ33787342-550C05E0-BE58-4391-9398-E6CCFFC197F5Q33845281-F008C336-33DB-4D06-BE3D-C2654F4E6115Q33850411-3A63C899-6191-4450-BE19-FBB999623811Q33920251-BECBB847-46BB-4BB6-827C-662C80FC2037Q34100703-CCC375C3-B61B-48D4-8986-0B05C0E33683Q34183725-D5B825F4-A374-4D0E-82CD-FC87087C3FD5Q34224988-5978D167-83D3-4775-80EF-DE11ADC52891Q34299338-CA78487F-12B7-4E97-A926-43781E38C4D2Q34381164-9CC9C873-CEB4-4EDB-9AE2-00ACD266A4CCQ34508284-0AA4E582-A4D6-4511-96F5-C7AA32BDD067Q34552244-AD46464A-7C45-45ED-B188-1F8EF76E4ED5Q34810678-D9948865-FC56-4F02-A42D-6C5A6E4F845AQ35068792-84BC7F0F-D444-4FCF-A18E-151AB318F49AQ35187475-1BDCFE57-70C5-4192-A0E4-305A59861F1AQ35587423-57A421DD-B79A-44BB-A64C-5D883E17370DQ35746518-3AAAF4EF-665F-4775-9D56-36C7069BB418Q35808114-DB3376A7-F27B-4334-AF01-DF8811F36617
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neuroinflammation in Parkinson's disease.
@en
Neuroinflammation in Parkinson's disease.
@nl
type
label
Neuroinflammation in Parkinson's disease.
@en
Neuroinflammation in Parkinson's disease.
@nl
prefLabel
Neuroinflammation in Parkinson's disease.
@en
Neuroinflammation in Parkinson's disease.
@nl
P1476
Neuroinflammation in Parkinson's disease
@en
P2093
Sheela Vyas
P304
P356
10.1016/S1353-8020(11)70065-7
P478
18 Suppl 1
P577
2012-01-01T00:00:00Z